Newsfeeds - Spark Newswire

1 minute read

Movers

Why Ideaya Biosciences Shares Are Falling Sharply During Wednesday’s After-Hours Session

Today, 5:30 PM

Ideaya Biosciences Inc (NASDAQ: IDYA) shares are trading lower by 10.07% to $11.25 during Wednesday's after-hours session. The company announced an $80 million common stock offering.

IDYA

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 5:30 PM

Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million.

ATXI

5 minute read

Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:30 PM

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.

AKTX

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 5:30 PM

AKTX

1 minute read

IDEAYA Shares Jump On Positive Interim Data From Eye Cancer Trial

By Vandana Singh

Today, 5:30 PM

The shares of oncology-focused Ideaya Biosciences Inc (NASDAQ: IDYA) are trading higher after interim data from its solid tumor candidate darovasertib with cancer…

IDYA

4 minute read

Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 5:30 PM

Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.

AKTX

3 minute read

US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises

By Lisa Levin

Today, 5:30 PM

Pre-open movers

BYDDF

1 minute read

Oracle, JPMorgan And 3 Stocks To Watch Heading Into Monday

By Lisa Levin

Today, 5:30 PM

With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:

IDYA

2 minute read

Earnings

Looking Into IDEAYA Biosciences’s Return On Capital Employed

By Benzinga Insights

Today, 5:30 PM

Benzinga Pro data, IDEAYA Biosciences (NASDAQ:IDYA) reported Q2 sales of $5.85 million. Earnings fell to a loss of $22.06 million, resulting in a 57.4% decrease from last quarter.

IDYA

1 minute read

IDEAYA Shares Climb As Initial Stage Uveal Melanoma Study Kick-off In Australia

By Ragothaman Srinivasan

Today, 5:30 PM

IDEAYA Biosciences (NASDAQ: IDYA) has initiated Investigator Sponsored Trial to evaluate darovasertib as monotherapy in neo-adjuvant and adjuvant settings in primary, non-metastatic uveal melanoma (UM) patients.

IDYA